Abeona Therapeutics Incの機関の所有権
Abeona Therapeutics Incの機関の所有権は何ですか。
Abeona Therapeutics Incの機関の所有権は10.77%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
NASDAQのセクタHealth Careにおける機関の所有権の企業と比べるAbeona Therapeutics Inc
Abeona Therapeutics Incは何をしますか。
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Abeona Therapeutics Incと類似の機関の所有権
- Molecular Data Incの機関の所有権は10.76%です。
- Gladstone Commercial Corpの機関の所有権は10.76%です。
- Huanxi Mediaの機関の所有権は10.76%です。
- TCI Expressの機関の所有権は10.76%です。
- Engencoの機関の所有権は10.76%です。
- Aroa Biosurgeryの機関の所有権は10.76%です。
- Abeona Therapeutics Incの機関の所有権は10.77%です。
- Echelonの機関の所有権は10.77%です。
- Opera Ltdの機関の所有権は10.78%です。
- ABB Indiaの機関の所有権は10.78%です。
- Gatiの機関の所有権は10.78%です。
- Standard Lithiumの機関の所有権は10.79%です。
- BlackRock MuniYield Investment Fundの機関の所有権は10.79%です。